FRATES JAMES M (CIK 1235598) reported 8 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-03-09). Recent activity: Buy AMLX (95,990 shares), Sell AMLX (7,909 shares), Sell AMLX (3,557 shares), Sell AMLX (3,326 shares), Sell AMLX (10,558 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-09 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | Buy | 95,990 | $0 |
| 2026-03-04 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | Sell | 7,909 | $114,839 |
| 2026-02-04 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | Sell | 3,557 | $52,110 |
| 2026-01-08 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | Sell | 3,326 | $36,952 |
| 2025-10-02 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | Sell | 10,558 | $154,675 |
| 2025-07-31 | Sage Therapeutics, Inc. (SAGE) | Director | Sell | 2,845 | $0 |
| 2025-04-02 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | Sell | 10,896 | $37,809 |
| 2025-03-10 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | Buy | 68,420 | $0 |
Source: SEC Form 4 filings · as of 2026-03-09